NCT06108726 2023-10-31
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Northern Jiangsu People's Hospital
Phase 2 Unknown
Clinical Trials
12 trialsNCT04811001 2023-02-21
CAPLAND
Fondazione Ricerca Traslazionale
Phase 2 Unknown
NCT05651269 2022-12-15
Milciclib in Combination With Gemcitabine in Advanced NSCLC
Tiziana Life Sciences LTD
Phase 2 Unknown
NCT05117658 2022-08-04
Study of HA121-28 in Patients With Non-Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT05065398 2022-01-21
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05165355 2022-01-18
ATHEM
Tongji University
Phase 2 Unknown
NCT04506242 2020-09-09
Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04164745 2019-11-15
Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03416231 2018-01-31
Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)
Affiliated Hospital of North Sichuan Medical College
Phase 2 Unknown
NCT02631460 2015-12-16
S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC
Sun Yat-sen University
Phase 2 Unknown
NCT02272127 2014-10-22
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT01932229 2013-08-30
An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib
Sheba Medical Center
Phase 2 Unknown